In vitro activity of cefpodoxime against staphylococci in comparison to other cephalosporins

  • F. Schumacher-Perdreau
  • B. Jansen
  • G. Peters
New Antimicrobial Agents

Keywords

Internal Medicine Cephalosporin Cefpodoxime Vitro Activity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fujimoto K, Shihara S, Yanagisawe H, Ide J, Nakayama E, Nakao H, Sugawara S, Iwata M Studies on orally active cephalosporin esters. Journal of Antibiotics 1987, 40: 370–384.PubMedGoogle Scholar
  2. 2.
    Utsui Y, Inove M, Mitsuhashi S In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1987, 31: 1085–1092.PubMedGoogle Scholar
  3. 3.
    Chin NX, Neu HC In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Antimicrobial Agents and Chemotherapy 1988, 32: 671–677.PubMedGoogle Scholar
  4. 4.
    Jones RN, Barry AL Antimicrobial activity and disc diffusion susceptibility testing of U-76, 253A (R-3746), the active metabolite of the new cephalosporin ester, U-76, 252 (CS-807). Antimicrobial Agents and Chemotherapy 1988, 32: 443–449.PubMedGoogle Scholar
  5. 5.
    Knapp CC, Sierra-Madero J, Washington JA Antibacterial activities of cefpodoxime, cefixime and ceftriaxone. Antimicrobial Agents and Chemotherapy 1988, 32: 1896–1898.PubMedGoogle Scholar
  6. 6.
    Fass RJ, Helsel VL In vitro activity of U-76, 252 (CS-807), a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1988, 32: 1082–1085.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1991

Authors and Affiliations

  • F. Schumacher-Perdreau
    • 1
  • B. Jansen
    • 1
  • G. Peters
    • 1
  1. 1.Institute of Medical Microbiology and HygieneUniversity of CologneCologne 41FRG

Personalised recommendations